In mammals, ␤1 integrin adhesion receptors generate signals that mediate cell spreading, migration, proliferation, and survival. CD98, a heterodimeric transmembrane protein, physically associates with certain integrin ␤ subunit cytoplasmic domains (tails) via its heavy chain, CD98hc (SLC3A2), and loss of CD98hc impairs integrin signaling. Here we have used the lack of CD98hc interaction with the Drosophila integrin ␤PS tail for a homology scanning analysis that implicated the C-terminal 8 residues of ␤3 (Thr 755 -Thr 802 ) in CD98hc binding. We then identified point mutations in the ␤3 C terminus (T755K and T758M) that abolish CD98hc association and a double mutation in the corresponding residues in the ␤PS tail (K839T,M842T), which resulted in gain of CD98hc interaction. Furthermore, the loss of function ␤3(T755K) mutation or the gain of function ␤3/␤PS(K839T,M842T) led to a loss or gain of integrin-mediated cell spreading, respectively. Thus, we have identified critical integrin residues required for CD98hc interaction and in doing so have shown that CD98c interaction with the integrin ␤ tail is required for its ability to mediate integrin signaling. These studies also provide new insights into how CD98hc may cooperate with other cytoplasmic domain binding proteins to modulate integrin functions and into the evolution of integrin signaling.
In mammals, ␤1 integrin adhesion receptors generate signals that mediate cell spreading, migration, proliferation, and survival. CD98, a heterodimeric transmembrane protein, physically associates with certain integrin ␤ subunit cytoplasmic domains (tails) via its heavy chain, CD98hc (SLC3A2), and loss of CD98hc impairs integrin signaling. Here we have used the lack of CD98hc interaction with the Drosophila integrin ␤PS tail for a homology scanning analysis that implicated the C-terminal 8 residues of ␤3 (Thr 755 -Thr 802 ) in CD98hc binding. We then identified point mutations in the ␤3 C terminus (T755K and T758M) that abolish CD98hc association and a double mutation in the corresponding residues in the ␤PS tail (K839T,M842T), which resulted in gain of CD98hc interaction. Furthermore, the loss of function ␤3(T755K) mutation or the gain of function ␤3/␤PS(K839T,M842T) led to a loss or gain of integrin-mediated cell spreading, respectively. Thus, we have identified critical integrin residues required for CD98hc interaction and in doing so have shown that CD98c interaction with the integrin ␤ tail is required for its ability to mediate integrin signaling. These studies also provide new insights into how CD98hc may cooperate with other cytoplasmic domain binding proteins to modulate integrin functions and into the evolution of integrin signaling.
Integrins mediate cell-cell and cell-matrix adhesion to support the development and functioning of multicellular organisms (1) (2) (3) (4) . In addition to mediating adhesion, these receptors are bona fide signaling receptors that regulate cytoskeletal organization, gene expression, and cell proliferation, differentiation, and survival. These effects are achieved via signaling pathways including Rho GTPases and kinases (1, 4 -7) ; the actions of these signaling pathways result in the cell spreading that follows adhesion to integrin ligands. Integrins are composed of non-covalently associated ␣ and ␤ subunits, the N terminus of each subunit is extracellular, and a single transmembrane domain separates the ϳ700 -1200-residue extracellular domain from a usually short (5-65 residue) cytoplasmic domain or tail (8) . The cytoplasmic domains of integrins play an essential role in integrin signaling by interacting with cytoplasmic proteins (9) . In addition, a genetic complementation strategy identified an interaction between a transmembrane protein, CD98, and the integrin ␤1A cytoplasmic domain (10) , suggesting that this interaction might also participate in integrin signaling.
CD98 heterodimers, comprised of a heavy chain, CD98hc (SLC3A2, 4F2hc), and one of several light chains (11) interact with integrins via the cytoplasmic domain of CD98hc (10, 12) , a type II transmembrane protein. CD98hc cross-linking or overexpression activates (13) (14) (15) and CD98hc deletion inhibits (16) certain integrin-regulated signaling pathways. The CD98hc intracellular domain is necessary and sufficient for interaction with integrins and promotion of integrin signaling (12, 16) , whereas the CD98hc extracellular domain interacts with the light chains to promote amino acid transport (12) . These data suggest that the CD98hc-integrin interaction is required for its capacity to mediate integrin signaling. Here, we have tested this hypothesis by fine mapping of the integrin residues required for binding to CD98hc. Authentic CD98hc orthologues are not evident in invertebrates (17), and we report that an invertebrate ␤ integrin cytoplasmic domain, Drosophila ␤PS, fails to bind mammalian CD98hc. We use this species difference and a "homology scanning" strategy to identify two residues in the integrin ␤ tail that control the binding specificity for CD98hc but have no effect on talin binding. Using loss of function and gain of function mutants at these residues, we find that CD98hc binding to integrin ␤ tails is required for efficient adhesion-dependent cell spreading. Thus, we show that the interaction of CD98hc with the integrin ␤ subunit tail mediates adhesive signaling.
MATERIALS AND METHODS
Antibodies-The hybridoma cell line 4F2(C13) (anti-CD98) was purchased from American Type Culture Collection. The CD98 antibody was purified from ascites produced in pristineprimed BALB/c mice by protein A affinity chromatography. Mouse CD98hc-specific antibody (M20) and anti-FAK 2 antibody (C20) were purchased from Santa Cruz Biotechnology and talin antibody (clone 8d4) was from Sigma. An antibody specific for phosphorylated FAK Tyr 576 was obtained from BIOSOURCE. Monoclonal antibody against human ␣IIb␤3 (D-57) has been described previously (18) .
Cell Culture-Mouse embryonic fibroblasts (MEF) were derived from CD98hc conditional homozygote embryos as described previously. 3 Briefly, exon 1, encoding the transmembrane domain of CD98hc, and exon 2 were targeted and flanked with lox P sites. Two homologous ES cell recombinant clones were injected into host blastocysts. Germ line transmission was obtained, and heterozygote animals were bred to obtained homozygotes CD98hc fl/fl mice. The CD98hc Ϫ/Ϫ MEFs were generated by infecting CD98hc fl/fl MEFs with Adeno-CRE encoding CRE recombinase. 3 MEFs were cultured in complete Dulbecco's modified Eagle's medium with high glucose (Invitrogen), supplemented with 10% fetal bovine serum (HyClone), 0.1 mM nonessential amino acids (Invitrogen), 2 mM L-glutamine (Invitrogen), 1% penicillin/streptomycin (Sigma), 1% HEPES (Invitrogen), 0.2% mercaptoethanol. Chinese hamster ovary cell line (CHO) expressing the polyoma large T antigen were transiently transfected with CD98hc, ␣IIb␤3, or its mutant using Nucleofector II device (AMAXA Biosystems). Similar expression levels were checked by flow cytometry as described below.
Flow Cytometry-Analytical two color flow cytometry was performed as described previously (19) . Expression levels of transiently transfected CHO cells were assessed by biotinylated D-57 binding and 488 Alexa Flour-labeled streptavidin (Molecular Probes). CD98hc expression levels in MEF cells were measured by anti-mouse CD98hc (clone H202-141, Pharmingen) binding. Goat fluorescein isothiocyanate-conjugated anti-rat IgG was obtained from BioSource International and was used as secondary antibody for anti-CD98hc detection.
DNA Constructs and Recombinant Proteins-cDNA encoding integrin cytoplasmic domains joined to four heptad repeats were cloned into the modified pET-15 vector as described previously (20) and were biotinylated in vivo as described (21) . The repeats form parallel coiled-coil dimers so that the tails are dimerized and parallel, thus, mimicking clustered integrins. CD98hc also binds to a heterodimeric construct formed with ␣IIb and ␤3 tails that mimic the cytoplasmic face of a single integrin (22) . Point mutations in ␤3 tails were performed utilizing the QuikChange kit (Stratagene) or, for the swap mutations between ␤3 and ␤PS cytoplasmic tails, with megaprimer polymerase chain reaction techniques. Recombinant expression in BL21(DE3) cells (Novagen) and biotinylation of the avidin tag as well as purification of the recombinant products were done in accordance with the manufacturer's instruction (Novagen), with an additional purification step on a reverse phase C18 high performance liquid chromatography (HPLC) column (Vydac). Polypeptide masses were confirmed by matrix-assisted laser desorption time of flight mass spectrometry and varied by less than 0.1% from those predicted by the desired sequence. Synthetic peptides used in the competition assays were synthesized on an ABI 430 peptide synthesizer and were 95% homogeneous as judged by a reverse phase C18 HPLC column (Vydac).
Construction of ␤3 Mutants or Chimera-Point mutations in ␤3 or ␤PS were performed utilizing the QuikChange kit (Stratagene). To generate ␤3/␤PS chimera, whereby the cytoplasmic domain of ␤3 was replaced by ␤PS, a SphI restriction enzyme site was created via a silent mutation at nucleotide 1899 (C to A) of ␤3 cDNA sequence using site-directed mutagenesis. ␤3␤PS and ␤3␤PS(K839T,M842T) chimeras were generated by ligation of PCR-generated ␤3 transmembrane domain and ␤PS cytoplasmic domain fusion sequences into the wild type ␤3 expressing vector, CDHYG3A.SphI (23) .
Cell Lysates-MEF cells were washed 3 times in phosphatebuffered saline before they were lysed in buffer A (1 mM Na 3 VO 4 , 50 mM NaF, 40 mM sodium pyrophosphate, 10 mM Pipes, 50 mM NaCl, 150 mM sucrose, 1% Triton X-100, 0.5% deoxycholate, and protease inhibitors (Roche Applied Science), pH 6.8) for 30 min at 4°C. The cell lysate was then centrifuged at 14,000 rpm before supernatant was used for affinity chromatography.
Integrin Tail Affinity Chromatography (HPLC)-HPLC was performed as described (20) . Briefly, 1.2 mg of each recombinant integrin cytoplasmic domain dissolved in 1 ml of 20 mM Pipes, 50 mM NaCl, pH 6.8 (PN buffer), plus 0.2 ml of 100 mM sodium acetate was bound to 150 l of immobilized Neutravidin TM beads (Pierce), 50% slurry at 4°C overnight. Neutravidin beads were then washed 3 times in PN Buffer and 2 times in buffer A (1 mM Na 3 VO 4 , 50 mM NaF, 40 mM sodium pyrophosphate, 10 mM Pipes, 50 mM NaCl, 150 mM sucrose, 0.5% Triton X-100, pH 6.8). Equal loading of Immobilized Neutravidin beads with recombinant proteins was verified by Coomassie Blue staining of SDS-PAGE profiles of SDS eluted proteins. Beads were added to cell lysates diluted in buffer A and protease inhibitors and incubated overnight at 4°C and then washed 5 times with buffer A. 75 l of 2ϫ reducing SDS-sample buffer was added to the beads, and the mixture was heated 95°C for 10 min. After 14,000 rpm centrifugation in a tabletop microcentrifuge (Beckman, GS15R), the supernatant was fractionated by SDS-PAGE and analyzed by Western blotting.
Cell Spreading Assays-Assays of cell spreading on fibrinogen or fibronectin were performed as described previously (24) . Briefly, 24-well plates were coated with 10 g/ml fibrinogen or fibronectin in a coating buffer (150 mM NaCl, 50 mM Na 2 HPO 4 , pH 8.0, at 4°C overnight) and blocked with 1% heat-denatured bovine serum albumin for 60 min at 37°C. Cells were detached, washed twice with Dulbecco's modified Eagle's medium plus 1 mg/ml bovine serum albumin, and resuspended in the same medium at 5 ϫ 10 5 cells/ml. The cells (5 ϫ 10 4 cells/well) were permitted to attach at 37°C and incubated for the times indicated. Unattached cells were washed away with phosphatebuffered saline, attached cells were fixed with 3.7% formaldehyde for 5 min at room temperature, washed twice with PBS, and stained with 0.5% crystal violet in 25% methanol for 30 min at room temperature, washed with distilled water 3 times, and observed with bright field microscopy. Photographic images were acquired with FAST1394 CCD. Cells that exhibited flattening and the presence of lamellipodia under microscope examination were scored as spreading cells. Cell area was assessed by Image J 1.32 software (National Institutes of Health).
RESULTS

CD98hc Is Required for ␣IIb␤3 Integrin-mediated Cell
Spreading-Previous studies with CD98hc-deficient embryonic stem cells suggested that CD98hc is important in ␤1 inte-grin signaling (16) . As a further test of that idea, we used conditional null CD98 fl/fl MEF and examined the effect of in vitro deletion of CD98hc by adenovirus-mediated infection of Cre recombinase (Fig. 1A) . As expected, deletion of CD98hc blocked ␣5␤1 integrin-mediated cell spreading on fibronectin, a consequence of ␤1 integrin signaling (Fig. 1, B and C) . Having confirmed that acute deletion of CD98hc in MEFs had similar effects to those observed in ES cells, we next sought to establish a system to enable mapping of CD98hc binding sequences in integrin ␤ cytoplasmic domains. Previous studies showed that CD98hc-expressing and CD98hc-deficient MEFs express no ␤3 integrins. 4 Because ␤3 but not ␤1 integrins mediate cell attachment to fibrinogen in most cell types, the platelet integrin can be used as a model to analyze structural requirements for integrin signaling in these cells (25) . We expressed recombinant integrin ␣IIb␤3 in these MEFs (Fig. 1D ) and ␣IIb␤3-transfected cells, but not untransfected cells, adhered to fibrinogen (not shown). Because, CD98hc interacts with the ␤3 cytoplasmic domain (22) and integrin ␣IIb␤3, 4 we next examined the role of CD98hc in ␣IIb␤3-mediated cell spreading. The CD98hc null MEFs attached to fibrinogen but failed to spread; in contrast, the floxed CD98hc parental cells spread extensively (Fig. 1, E and F) . Thus, we have established a system in which cell spreading is mediated by a recombinant integrin (␣IIb␤3) and is CD98hc-dependent.
Mapping Integrin Sequences Required for CD98hc Binding-Having established an assay for CD98hc-dependent integrin signaling in a cell in which we could manipulate integrin sequences, we next sought a CD98hc non-binding integrin for a homology scanning analysis similar to that used to map the filamin binding sequence in integrin ␤ tails (26) . We first compared the ␤3 tail sequence to that of ␤7 and ␤1D, two ␤ tails that fail to bind CD98hc (22) , and noted substantial divergence from ␤3 sequence. We also examined ␤PS from Drosophila melanogaster because the cytoplasmic tail of ␤PS is 68% identical with the human ␤3 cytoplasmic domain ( Fig. 2A) and because Drosophila were reported to lack an authentic CD98hc orthologue (17) . Ϫ/Ϫ MEFs were plated on 10 g/ml fibronectin, and cell area was measured at the indicated times. D, FACS analysis of expression levels of ␣IIb␤3 integrins. 48 h after CD98-expressing or CD98hc-deficient MEFs were transiently transfected with cDNAs encoding integrin ␣IIb and ␤3 and stained for ␣IIb␤3 expression using D57 antibody to generate the indicated dot plots. The histograms exhibit the expression of integrin ␣IIb␤3 in the gated integrinpositive and propidium iodide (PI)-negative populations. E, CD98hc fl/fl or CD98hc Ϫ/Ϫ MEFs transiently expressing ␣IIb␤3 were plated on fibrinogen and allowed to adhere for 20min. Twenty min after adhesion to 10 g ml Ϫ1 fibrinogen, the surface area of the MEFs was measured using Image J. wt, wild type. F, time course of cell spreading on fibrinogen. CD98hc fl/fl or CD98hc Ϫ/Ϫ cells were adhered to fibrinogen as described in E, and spreading was measured at the indicated times after attachment. *, p Ͻ 0.005. Because the complete genome of D. melanogaster is now available, we performed a BLAST search with the human CD98hc sequence and identified maltase H precursor (P07190), which is similar to a region of the CD98hc extracellular domain but does not appear to have a transmembrane domain and, thus, does not appear to be a true orthologue. Similarly, both UniProtKB/ TrEMBL and Homologene databases list only vertebrate CD98hc orthologues. Consistent with a lack of a CD98hc orthologue in Drosophila, the ␤PS cytoplasmic domain failed to bind human CD98hc (Fig. 2B) . In contrast, mammalian talin, a critical integrin cytoplasmic domain-binding protein in all species so far examined (27, 28) , bound as strongly to the ␤PS tail as it did to the ␤3 tail, confirming the functionality of the ␤PS cytoplasmic domain. Thus, CD98hc binds to ␤3 but not to the similar ␤PS cytoplasmic domain.
We next studied the effect of exchanges between ␤3 and ␤PS on CD98hc binding. CD98hc binds to ␤1A but not to its splice variant, ␤1D (22) . The main differences between these two integrins are in the C-terminal amino acids. Therefore, we hypothesized that the ␤ sequences important for CD98hc binding are located within the C-terminal region of the cytoplasmic domain of ␤3. Swapping the C-terminal eight amino acids between ␤3 and ␤PS switched CD98hc binding phenotypes (Fig. 3A) . ␤PS tail chimeras containing the last eight amino acids of ␤3 (␤PS (839 -846 ␤3)) bound CD98hc to a similar extent as full-length ␤3. Conversely, a ␤3 tail containing the C-terminal eight amino acids of ␤PS (␤3 (755-762 ␤PS)) lost its capacity to bind CD98hc (Fig. 3B) . Thus, these exchanges indicate that residues 755-762 of the ␤3 tail are critical for high affinity CD98hc binding.
We next employed a competitive inhibition approach to test the importance of the C terminus of the integrin ␤ subunit in CD98hc binding. Synthetic peptides that spanned either the C-terminal or the N-terminal region of the ␤3 cytoplasmic domain were used to compete for CD98hc binding to the full-length ␤3 tail. The C-terminal peptide (␤3 (748 -762)) competed for CD98hc binding with a calculated IC 50 of ϳ300 M (Fig. 3C) . In sharp contrast, the N-terminal peptide, ␤3 (721-738), had no effect at concentrations up to 10 mM. The difference in activity of these two peptides is not likely to be due to charge effects since they have similar calculated (ExPASy ProtParam) isoelectric points (␤3 (748 -762) pI ϭ 8.59; ␤3 (721-738) pI ϭ 8.50). Thus, these data together with the data obtained from the homology exchange mutants suggest that the C-terminal region of the ␤3 cytoplasmic domain binds to CD98hc.
Amino Acid Residues Essential for CD98hc
Interaction-To assess the role of individual amino acid residues within the ␤3 cytoplasmic domain that are important for CD98hc binding, we generated point-mutated ␤-tail proteins. Because swapping the C-terminal eight amino acids between ␤3 and ␤PS led to a reversal in CD98hc binding, we studied differences in the sequence of the C-terminal end. Truncation of the three C-terminal amino acids of ␤1A does not influence CD98hc binding, whereas deleting the last seven residues abolishes it (22) , suggesting that ␤3 Arg 760 -Thr 762 is dispensable for CD98hc binding. Consistent with this hypothesis, CD98hc bound to a three-residue truncation of ␤3 (␤3(760X)) (Fig.  4A) . A comparison of the C-terminal sequences of CD98hc binding integrins (␤3 or ␤1A) with non-CD98hc binding ␤ integrins (␤1D or ␤PS) (Fig. 4B) The foregoing experiments showed that substitution of ␤3 Thr 755 to Lys 755 resulted in a loss of CD98hc binding to the ␤3 tail. This residue is a Val in ␤1A, an integrin that interacts with CD98hc, suggesting that a Thr is not absolutely required in this position for CD98 binding. Furthermore, these data suggest a Lys is not permitted in this position for retention of CD98 binding; indeed, a Lys substitution for Val 796 in ␤1A, which corresponds to the Thr 755 position in ␤3, led to a decrease in CD98hc binding with no effect on talin binding (Fig. 4B) .
Two Threonine Substitutions in ␤PS Results in CD98hc Binding-The experiments described above identify two amino acids within the C-terminal region of ␤3 involved in CD98hc binding (Thr 755 and Thr 758 ). The corresponding residues in 755-762 839-846 FIGURE 3. CD98hc binding involves the C terminus of ␤3. A, amino acid sequences of C-terminal swapmutations of ␤3 with the ␤PS cytoplasmic domain. B, affinity chromatography using lysate of MEFs was performed as described in Fig. 2 , and bound CD98hc was detected by immunoblotting. Equivalent loading of the recombinant ␤ tails was verified by Coomassie Blue staining. CD98hc binds to ␤3 and to ␤PS chimeras containing the C-terminal eight amino acids of ␤3 (␤PS (839 -846 ␤3)). C, MEF lysates were added to immobilized Neutravidin beads loaded with ␤3-cytoplasmic tail proteins in the absence or presence of ␤3 tail synthetic peptides. Bound CD98hc was detected by SDS-PAGE separation and immunoblotting. Bound CD98hc was quantified by densitometry, and these values were used to calculate percentage inhibition ϭ 100 ϫ (I 0 ϪI)/I 0 , where I 0 ϭ intensity in the absence of a competitor, and I ϭ intensity in the presence of competitor.
␤PS are a Lys 839 and Met 842 . Changing both of these residues in ␤PS cytoplasmic domain to Thr resulted in a dramatic gain of CD98hc binding function in ␤PS (K839T,M842T) (Fig. 5A) . Consistent with the loss of CD98hc when either Thr 755 or Thr 758 in integrin ␤3 tail was mutated (see Fig. 4 ), single Thr substitutions at either at Lys 839 or at Met 842 resulted in no increase of CD98hc binding (Fig. 5A) . Thus, introducing Thr at position 839 and 842 into ␤PS resulted in a gain of CD98hc binding function.
Integrin-CD98hc Interaction Mediates Adhesive Signaling-Having defined conservative substitutions that selectively alter CD98hc-integrin interactions, we tested the potential biological role of CD98hc-integrin interaction. CHO cells expressing either wild type ␣IIb␤3 integrin or a mutant in which Thr 755 had been replaced with lysine (T755K) were studied. Similar expression levels of recombinant proteins were confirmed by FACS analysis (Fig. 6A) . Cells expressing ␤3(T755K) exhibited markedly reduced spreading on fibrinogen (Fig. 6B) . This difference was not due to generalized defects in cell spreading because both cell lines spread to a similar extent on fibronectin, a ligand for endogenous hamster integrin ␣5␤1 (Fig. 6B) . Thus, a point mutation that disrupts CD98hc binding to ␤3 resulted in impaired cell spreading.
Conversely, we asked whether a gain of CD98hc binding function mutant of ␤PS (K839T,M842T), as described above, would enhance cell spreading. We created chimeras in which the extracellular and transmembrane domains of ␤3 were joined to the cytoplasmic domain of ␤PS and examined the spreading of cells expressing this mutant on the ␤3-specific ligand, fibrinogen. Wild type ␤3 and the two chimeras, ␤3␤PS and ␤3␤PS(K839T,M842T), were expressed at similar levels when they were co-transfected with a cDNA encoding integrin ␣IIb (Fig. 6C) . The cells expressing ␣IIb␤3␤PS exhibited markedly A, ␤3(T755K) or ␤3(T758K) mutations disrupt CD98hc interaction. Affinity chromatography was performed as described in Fig. 2 . Lysate represents 10% of the starting lysate. B, a single amino acid mutation in ␤1A (V796K), which corresponds to ␤3 Thr 755 , disrupts CD98hc interaction with ␤1A cytoplasmic tail. As reported previously (22) , CD98hc interacts with ␤1A but not with ␤1D. Talin binding to ␤ tails is not disrupted by any of these mutations. Loading of each tail was assessed by Coomassie Blue staining (Loading). reduced spreading compare with those expressing ␣IIb␤3 (Fig. 6D) . Strikingly, the cells expressing ␣IIb␤3␤PS(K839T,M842T) spread to a much greater extent than those expressing ␣IIb␤3␤PS (Fig. 6D) . Thus, the CD98hc-integrin interaction mediates the signaling events required for integrin-dependent cell spreading.
DISCUSSION
Our results implicate the C-terminal eight residues of the integrin ␤3 tail in CD98hc interaction and pinpoint Thr 755 and Thr 758 as being of particular significance. This site is distinct from both the phosphotyrosine binding-like and membrane proximal binding sites for talin that are responsible for integrin affinity modulation (29) (30) (31) . Because CD98hc does not appear to interact with integrin tail sites required for affinity modulation, these data explain why deletion of CD98hc fails to alter integrin affinity (16) . Furthermore, the Src family kinases require the C-terminal 3 residues of ␤3 for binding (21), whereas CD98hc does not, suggesting that the CD98hc and Src binding sites may be distinct. In contrast, the filamin binding site in ␤7 (32) spans residues analogous to the CD98hc site in ␤1A, suggesting that filamin might inhibit CD98hc binding to integrin ␤ tails, thus partially explaining the capacity of filamin to block cell spreading and cell migration when it binds to integrin ␤1A (26) . In sum, we have identified critical residues required for CD98hc binding and in doing so have provide new insights into how this protein may cooperate with other cytoplasmic domain binding proteins to modulate integrin function.
The identification of residues critical for CD98hc binding also suggests new directions for analysis of the regulation of the CD98hc-integrin interaction. This region of ␤3 is flexible and unstructured in aqueous solution (33) (34) (35) ; however, when the ␤3 tail interacts with DPC micelles, this region has a strong helical propensity, and the two critical Thr residues would come to lie C, FACS analysis of expression levels of ␣IIb␤3, ␣IIb␤3␤PS chimera, or ␣IIb␤3␤PS (K839T,M842T) mutants in CHO cells 48 h after transfection. All constructs were expressed at a comparable levels (fluorescence intensity for ␣IIb␤3, 791 arbitrary units; for ␣IIb␤3␤PS chimera, 838 arbitrary units; for ␣IIb␤3␤PS (K839T,M842T) mutants, 803 arbitrary units). D, cell area measurements of CHO cells expressing ␣IIb␤3, ␣IIb␤3␤PS chimera, or ␣IIb␤3␤PS (K839T,M842T) mutants. CHO cells expressing recombinant integrins were allowed to spread on fibrinogen-coated coverslips. Quantification was done as described in B. Cell spreading on fibrinogen of CHO cells expressing ␣IIb␤3␤PS chimera was markedly reduced when compared with CHO cells expressing ␣IIb␤3 integrins. CHO cells expressing ␣IIb␤3␤PS (K839T,M842T) mutants spread to a greater extent than CHO cells expressing wild type ␣IIb␤3␤PS chimeras. *, p Ͻ 0.001. along the same face of a helix and be brought close to the plasma membrane (36) . Vinogradova et al. (36) propose that integrin activation and tail separation may modulate this membrane interaction and could, thus, regulate the CD98hc integrin interaction by changing the conformation of ␤3-(755-759). The membrane interaction could change the relationship of ␤3-(755-759) to the cytoplasmic membrane-proximal region of CD98hc, a site implicated in binding to integrins (14) . Furthermore, Thr 755 and Thr 758 have the potential to be phosphorylated; however, to date biochemical studies in platelets have demonstrated phosphorylation of Thr 751 and Thr 753 but not the two Thr residues critical for CD98hc binding (37) . Platelets express little CD98hc, 4 so future studies will be required to determine whether these residues can be phosphorylated in other CD98hc-expressing cells. Thus, our results raise the possibilities that integrin cytoplasmic domain separation or phosphorylation can regulate the integrin interaction with CD98hc.
Our finding that the interaction of CD98hc with the integrin ␤ tail is required for efficient integrin signaling explains some of the biological consequences of alternative splicing of the ␤1 integrin cytoplasmic domain. ␤1D is a splice variant that is expressed primarily in differentiated striated muscle, and ␤1D is less efficient than ␤1A in mediating cell spreading (38) and ERK mitogen-activated protein kinase-mediated cell proliferation (39) . Each of these events involves CD98hc-dependent integrin signaling (16) . The residue corresponding to ␤3 Thr 755 is Lys in ␤1D, and making this single substitution in ␤1A blocked CD98hc binding. Thus, our data explain the failure of ␤1D to bind to CD98hc (22) and the relative inability of ␤1D to engage the signaling pathways required for cell motility and proliferation. Furthermore, enforced replacement of ␤1A by ␤1D results in embryonic lethality with the plethora of developmental defects, in part caused by impaired migration of neuroepithelial cells (40) ; similarly, deletion of CD98hc results in early embryonic lethality (41) . Thus, our studies provide a biochemical explanation for some of the biological consequences of switching from the integrin ␤1A to ␤1D splice variant.
Our studies also suggest that the CD98hc-integrin ␤ tail interaction is a vertebrate specialization that has expanded the functional capacity of integrins. Authentic CD98hc first appears in the most primitive vertebrates (17) , and motifs required to bind CD98hc seem well preserved in vertebrates. For example a TNITY motif is found in the ␤3 tails of amphibians and fish (Fig. 7) . Furthermore, as shown here, ␤1A contains a Val at the locus corresponding to ␤3 Thr 755 . ␤1A capacity to bind CD98hc requires the absence of a Lys at this position, a feature also conserved in amphibians and fish. In contrast, in invertebrates such Drosophila and Strongylocentrotus, a Lys residue occurs at this position (Fig. 7) , and we show here that the presence of this Lys residue contributes to the failure of Drosophila ␤PS to bind to CD98hc. CD98hc promotes the integrin-dependent phosphorylation of pp125 FAK (16) , a central player in mammalian integrin signaling that mediates cell migration and survival (42) . In striking contrast to mammals, deletion of the pp125 FAK orthologue in Drosophila does not lead to lethality or to obvious defects in integrin function (43) . Thus, we propose that CD98hc-mediated integrin signaling pathways are a vertebrate specialization that enable the efficient adhesion-mediated activation of pp125 FAK and other key enzymes (16) required for integrindependent cell migration and cell survival.
